Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Leadership
Naming An Interim CFO Has Its Benefits
Appointing an interim CFO need not be avoided at all costs, according to a new study.
By
Vincent Ryan
| August 5, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Afferent Pharmaceuticals
Strategy
Merck Buys Cough Drug Developer for $1.25B
The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.
By
Katie Kuehner-Hebert
| June 10, 2016
Read More
